11/9/2020 | EMHYPFPV | Market Commentary: Bristol-Myers, Republic Services, Vereit, ConEd, Entergy, Ameren price
|
12/18/2019 | EMHYPFPV | Market Commentary: High-grade corporate bond supply winds down for year; FHLBank on tap; AbbVie firms
|
5/13/2019 | EMHYPFPV | Market Commentary: Nordic Investment Bank offers $1 billion; Nstar, Fidelity, Avangrid eyed
|
5/10/2019 | EMHYPFPV | Market Commentary: High-grade supply quiet; Fidelity, Avangrid, Nstar deals eyed; IBM eases; Bristol-Myers firms
|
5/9/2019 | EMHYPFPV | Market Commentary: Motorola, O’Reilly tap primary market; high-grade inflows rise; week’s deal volume strong
|
5/8/2019 | EMHYPFPV | Market Commentary: IBM prices $20 billion; Bell Canada, Reinsurance, AvalonBay, Honda, EIB among issuers
|
5/7/2019 | EMHYPFPV | Market Commentary: Principal Financial, Brixmor tap primary market; Bristol-Myers, Fidelity, T-Mobile eyed
|
5/6/2019 | EMHYPFPV | Market Commentary: Utilities American Water, Public Service, ConEd tap primary market; M&A funding deals eyed
|
5/3/2019 | EMHYPFPV | Market Commentary: Paccar Financial, Pacific Premier Bancorp price; heavy volume eyed; Starbucks softens
|
5/2/2019 | EMHYPFPV | Market Commentary: Starbucks, RBS, Eni, Florida Light in primary market; inflows decline; Bristol-Myers eyed
|
5/1/2019 | EMHYPFPV | Market Commentary: CNA Financial prices notes; T-Mobile, Bristol-Myers Squibb, Fidelity National eye deals
|
4/29/2019 | EMHYPFPV | Market Commentary: Norfolk, Lear, Celanese, AEP, Fannie Mae among high-grade issuers; Bristol-Myers eyed
|
4/25/2019 | EMHYPFPV | Market Commentary: Omers taps primary; Bristol-Myers deal on horizon; corporate inflows jump; Walmart soft
|
2/24/2017 | EMHYPFPV | Market Commentary: Fannie Mae, Pfizer sell notes; Bristol-Myers steady; Mizuho, Parker-Hannifin tighten
|
2/23/2017 | EMHYPFPV | Market Commentary: Danske, Nederlandse Waterschapsbank price; Fannie Mae offers notes; Bristol-Myers steady
|
2/22/2017 | EMHYPFPV | Market Commentary: Mizuho, Bristol-Myers, Paccar, Spire tap high-grade primary market; LyondellBasell improves
|
7/26/2012 | CVIGPF | Bristol-Myers Squibb files automatic shelf for stock, preferreds, debt
|
7/26/2012 | CVIGPF | S&P: Bristol-Myers Squibb notes A+, preferreds A-
|